Salivary Gland Disorder-1
Salivary Gland Disorder-1
Salivary Gland Disorder-1
GLAND
DISORDERS
CONTENT
INTRODUCTION
ANATOMY
• PAROTID GLAND
• SUBMANDIBULAR GLAND
• SUBLINGUAL GLAND
• MINOR SALIVARY GLANDS
SALIVA
CLASSIFICATION OF DISORDERS
DISORDERS
• Developmental Disorders
• Inflammatory - infectious
conditions
• Obstructive Disorders
• Viral Infections of Salivary
Glands
• Functional Disorders
• Autoimmune
• Neoplastic
SIALOGRAPHY
REFERENCES
INTRODUCTION
The salivary glands are exocrine glands that discharge saliva via a duct into the oral
cavity.
Divided into three major pairs of glands, including the parotid, submandibular and
sublingual glands, and over 400 to 1000 minor glands, including those in the tongue,
palatine tonsils, palate, lips and cheek.
• It is supplied by great
auricular nerve.
• It lies in the floor of the mouth between the mucus membrane and the
mylohyoid muscle.
• It is mostly mucus in
nature and weighs
about 3–4 g.
Traumatic/ Inflammator
Salivary y
Obstructive
• Mucocele, gland conditions
• Ranula disorders • Acute and
• Sialolithiasi chronic
s bacterial
sialadenitis
Viral
Functional infection
Disorders • Mumps,
• Xerostomia, • HIV
• Sialorrhea associated
(Ptyalism) salivary
gland
disorder
Developmental disorders
Management
- Antibiotics
- Palliative
• Hydrating the patient
• Stimulate the salivation by chewing sialogogues
• Improve the oral hygiene by debridement and irrigation.
• Symptoms
- Starts as a unilateral swelling at the
angle of the jaw.
- Low grade fever, and
- Salivary gland milking may yield
scanty saliva.
Manageme
nt
- Intraductal infusion of antibiotics
Mumps
• Epidemic parotitis.
• It is an acute nonsuppurative viral
parotitis caused by paramyxovirus.
• The term “mumps” is derived from
the Danish word “Mompen”
Pathogenesis
- Spreads by airborne droplet
dissemination.
- Incubation - 2–3 weeks.
- The virus localizes - salivary glands,
germinal tissues, and CNS.
Clinical Features -
- Predilection for the parotid gland.
- Highly contagious
- Occurs in children < 15 years of age with peak incidence being in the 4-
to 6-year-old group of children.
- Adults are rarely infected due to the immunity.
- Headache, fever, arthralgias, and malaise prior to development of
parotitis.
- It starts with an earache, pain around the gland, trismus, and
dysphagia.
- Pain is increased by salivary stimulation during meals.
- Inflamed and puffy parotid papilla.
- Palpation - swelling may be tense, rubbery, and firm with non-
pitting-type edema.
- Overlying skin - tensed and shiny without erythema.
- Swelling lasts for 1–5 days.
- It peaks during the first week and starts declining in the second or
third week Glands of both the sides enlarge,
- Xerostomia, trismus, cervical lymphadenitis.
which may be simultaneous or
one following the
other in 24–48 hours.
Treatment
• It is self-limiting,
• Symptomatic relief can be given by antipyretics.
• Antibiotics can be given to prevent the secondary infection.
Prevention:
Sialorrhea or Ptyalism
• Surgical Treatment
- Salivary gland resection
- Transposition of parotid duct
- Parotid duct ligation
• Clinically feature -
• Treatment is conservative,
• Maintenance of oral hygiene,
• Use of sialogogues (pilocarpine),
• Systemic pilocarpine—5–10 mg, 3/4 times daily,
• Sugarless gum chewing,
• Topical fluoride application to the teeth,
• Bromhexine 8 mg tds in adults,
Obstructive Disorders
Sialolithiasi
s
Sialolithiasis is the formation of
sialolith in the salivary duct or the
gland resulting in the mechanical
obstruction of the salivary flow.
Etiology
- Dehydration & Reduced food intake
- Medications - antihistamines,,
antidepressants & anticholinergics
- Gout - uric acid calculi
- Aging, inflammation, local irritation,
- Sjögren’s syndrome
- Tobacco smoking
- Radiotherapy
Clinical Features
• Submandibular sialoliths :
- Mobile stones < 5 mm located within the distal duct - endoscopy.
- Stones of 5 to 7 mm within the proximal duct or hilar region should
receive initial treatment endoscopically. If this is unsuccessful or the
stone becomes impacted, the next step is a transoral surgical
approach.
• Parotid Sialoliths-
Extravasation
Retention mucocele
mucocele
- Results from a injured - Appears due to
salivary gland duct and decrease or absence of
consequent spillage into glandular secretion
the soft tissue around produced by blockage of
this gland. salivary gland ducts.
Clinical Features
- Site of occurrence - lower lip (44–79%)> tongue > floor of mouth >
the buccal mucosa.
The incision is made through the mucosa in the lingual sulcus from
the first molar
to midline.
The gland is dissected free from the surrounding soft tissues and the
Wharton’s duct.
Clinical Feature -
- Middle-aged females
- Unilateral or bilateral enlargement of the parotid or
submandibular glands with an occasional or
swelling.
- Mild local discomfort, occasional pain, and
xerostomia.
- Fever, upper respiratory tract infection, tooth
extraction, or some other local inflammatory
disorder may precede the disease.
- Sometimes the lacrimal glands may be enlarged.
- FNAC can help diagnose the condition.
Management
- In some cases, the swelling might regress spontaneously.
- Persistent cases can be managed by sialadenectomy.
Sjögren’s Syndrome
Diagnosis
Management
WHO classification of
salivary gland tumors
(2017)
Pleomorphic
Adenoma
“Pleomorphic adenoma” suggested by Willis. It is the most
common salivary gland tumor
The tumor derives its name from the Greek words Pleos = many
and
morphus = form because of the heterogeneous nature of its
histologic
Clinical appearance.
Features
- In the case of the minor salivary glands of the palate, it may appear
to be fixed to the underlying palatal bone but does not invade or
erode the bone.
Clinical Features
Clinical Features
The slow biologic growth of adenoid cystic carcinoma along with a late
metastasis of the disease results in relatively favorable 5-year survival
rates.
• Indicated-
- Obstructive pathologies and duct anomalies,
- Degenerative changes in the gland,
- Chronic inflammatory conditions, and
- Intra- and extraglandular tumors.
Contraindication-
The duct orifice is enlarged using a lacrimal probe and cannulated with
a cannula
The selected dye is injected into the ductal system using a syringe with
gentle continuous pressure with simultaneous massage of the gland.
Once the patient feels some discomfort, dye injection is stopped. X-rays
are taken during the filling phase and emptying phase as well.
The X-rays show different patterns: